Production & Manufacturing

Nycomed to acquire of majority stake in Guangdong Techpool...

Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd. (Techpool),...

Merck’s Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates

Merck reported that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained virologic...

Biocon and Pfizer Enter Into Global Commercialization Agreement-Deliver Essential...

Biocon, Asia's premier biotechnology company, and Pfizer Inc., the world's leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for...

European vaccine development moves forward

The European Vaccine Initiative, a product development partnership supporting the development of vaccines against diseases of poverty, has brought together to Brussels manufacturers, biotech companies,...

Novartis announces agreement to develop influenza vaccines using revolutionary...

Novartis announced today an agreement with Synthetic Genomics Vaccines Inc. (SGVI) to apply "synthetic genomics" technologies to accelerate the production of the influenza seed strains...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read